The learning objectives for this talk are:
• Prevalence and impact of neurogenic bowel dysfunction (NBD)
• How understanding of the brain-gut axis helps understand pathophysiology
• Structured basis to conservative therapy in NBD
• How to use transanal irrigation
• Future potential for neuromodulation and targeting the microbiota to target the brain-gut axis
This topic is relevant due to an increasing prevalence of neurological disease. The brain-gut axis is being increasingly studied, especially neuromodulation and microbiota. Therapies are being developed without fully understanding mechanism
Anton Emmanuel says about the ICS that "it is important that bowel dysfunction is a part of the remit of the ICS, which should not be considered merely a bladder related organisation. Whilst there are national colorectal and gastroenterological groups, there is a need for an international institution to produce guidance and be a forum for discussion."
Anton Emmanuel's key new finding:
The complications of cancer therapy (especially pelvic cancers) include significant gastrointestinal symptoms which can be assessed and often treated.
To read Anton Emmanuel's full biography click here